At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,436 enrolled
Drug / intervention
Xpert MTB/RIF Tuberculosis diagnostic toolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CIDRZ 1201 - Optimizing Clinical Outcomes in HIV-Infected Adults & Children Using Xpert MTB/RIF in Zambia
In Brief
A clinical study evaluating Xpert MTB/RIF Tuberculosis diagnostic tool for Tuberculosis Diagnosis and HIV. Completed, enrolled 1,436 participants across 1 site.
Detailed Summary
This is a study to evaluate Xpert MTB/RIF as the first-line TB diagnostic test in HIV-infected adults and pediatric patients as a means to obtain faster, more accurate TB diagnosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis Diagnosis, HIV
CountriesZambia
CollaboratorsCenters for Disease Control and Prevention
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedJan 2014
Primary CompletionMar 2016
Study CompletionApr 2017
TodayJul 2026
First PostedJan 23, 2014
Enrollment StartAug 1, 2012
Primary CompletionMar 1, 2016
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.4 years ago
Interventions
Xpert MTB/RIF Tuberculosis diagnostic toolother
This is s new diagnostic tool that has been approved by WHO for the diagnosis of TB in HIV-infected patients in resource limited settings